Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference Summary - Thomson StreetEvents

Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference Summary

Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference Summary - Thomson StreetEvents
Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference Summary
Published Dec 02, 2025
8 pages (3946 words) — Published Dec 02, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of NBIX.OQ presentation 2-Dec-25 2:30pm GMT

  
Brief Excerpt:

...So Eric and team have now taken that medicine, INGREZZA, to now being around $2.5 billion alone this year, but only 10% of patients with tardive dyskinesia are being helped with the VMAT2 inhibitors today....

  
Report Type:

Brief

Source:
Company:
Neurocrine Biosciences Inc
Ticker
NBIX.OQ
Time
2:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Neurocrine Biosciences Inc To Host R&D Day Summary – 2025-12-16 – US$ 54.00 – Edited Brief of NBIX.OQ corporate analyst meeting</ 16-Dec-25 5:00pm GMT

Neurocrine Biosciences Inc To Host R&D Day Transcript – 2025-12-16 – US$ 54.00 – Edited Transcript of NBIX.OQ corporate analyst meeting</ 16-Dec-25 5:00pm GMT

Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference Transcript – 2025-12-02 – US$ 54.00 – Edited Transcript of NBIX.OQ presentation 2-Dec-25 2:30pm GMT

Neurocrine Biosciences Inc at Jefferies Global Healthcare Conference Summary – 2025-11-18 – US$ 54.00 – Edited Brief of NBIX.OQ presentation 18-Nov-25 12:00pm GMT

Neurocrine Biosciences Inc at Jefferies Global Healthcare Conference Transcript – 2025-11-18 – US$ 54.00 – Edited Transcript of NBIX.OQ presentation 18-Nov-25 12:00pm GMT

Neurocrine Biosciences Inc Q3 2025 Earnings Call Summary – 2025-10-28 – US$ 54.00 – Edited Brief of NBIX.OQ earnings conference call or presentation 28-Oct-25 8:30pm GMT

Neurocrine Biosciences Inc Q3 2025 Earnings Call Transcript – 2025-10-28 – US$ 54.00 – Edited Transcript of NBIX.OQ earnings conference call or presentation 28-Oct-25 8:30pm GMT

Neurocrine Biosciences Inc at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Summary – 2025-09-17 – US$ 54.00 – Edited Brief of NBIX.OQ presentation 17-Sep-25 4:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference Summary" Dec 02, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Neurocrine-Biosciences-Inc-at-Piper-Sandler-Healthcare-Conference-B16571096>
  
APA:
Thomson StreetEvents. (2025). Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference Summary Dec 02, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Neurocrine-Biosciences-Inc-at-Piper-Sandler-Healthcare-Conference-B16571096>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.